Under the agreement signed between Glenmark Specialty SA and the wholly-owned subsidiary of Lotus Pharmaceutical Co, Ltd (Lotus), Glenmark will be responsible for manufacturing and supply of Ryaltris.from Moneycontrol Business News https://ift.tt/3qIYTs8
Comments
Post a Comment